[1]
A. Gedebjerg, C. Johansen, K. Kragballe, and L. Iversen, “IL-20, IL-21 and p40: Potential Biomarkers of Treatment Response for Ustekinumab”, Acta Derm Venereol, vol. 93, no. 2, pp. 150–155, Aug. 2012.